Physician profile
Geetha Jeyabalan
NPI 1598956310
$3,549.17
in general payments reported to CMS, 2019-2025
16 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $252 · 2021: $539 · 2022: $653 · 2023: $940 · 2024: $504 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541 · Travel and Lodging: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.36 |
| Travel and Lodging | $208.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $843.83 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $612.22 | 2022-2025 | Endurant Iis, Symplicity G3 |
| Cook Medical LLC | $577.39 | 2022-2025 | Cook, Advance, Zenith Spiral-Z |
| Silk Road Medical, INC. | $431.35 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $368.50 | 2022-2023 | Indigo System |
| Smith+Nephew, INC. | $213.55 | 2019-2025 | Collagenase Santyl |
| Medtronic Vascular, INC. | $206.31 | 2019-2020 | |
| Boston Scientific Corporation | $115.96 | 2023-2025 | Varithena Administration Pack, Eluvia, Angiojet Ultra 5000a |
| Cordis US Corp. | $59.21 | 2021 | |
| Next Science LLC | $48.34 | 2023-2024 | Blastx, Xperience, Surgx |
| Kci USA, INC. | $24.95 | 2020 | |
| Ge Healthcare | $17.77 | 2022 | |
| Tactile Systems Technology INC | $14.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.81 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geetha Jeyabalan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.